Anacetrapib (MK-0859)

Anacetrapib (MK0859) is a potent, selective, reversible rhCETP and mutant CETP(C13S) inhibitor with IC50 of 7.9 nM and 11.8 nM, increases HDL-C and decreases LDL-C, does not increase aldosterone or blood pressure. Phase 3.

Price Not Available 10mg Anacetrapib (MK-0859) Supplier Page

Trivial name	N/A
Catalog Number	S2748
Molecular Formula	C30H25F10NO3
CAS#	875446-37-0
Inchi	InChI=1S/C30H25F10NO3/c1-14(2)22-11-23(25(43-4)12-24(22)31)21-6-5-18(28(32,33)34)9-17(21)13-41-15(3)26(44-27(41)42)16-7-19(29(35,36)37)10-20(8-16)30(38,39)40/h5-12,14-15,26H,13H2,1-4H3/t15-,26-/m0/s1
Inchi Key	MZZLGJHLQGUVPN-HAWMADMCSA-N
SMILES	CC1C(OC(=O)N1CC2=C(C=CC(=C2)C(F)(F)F)C3=CC(=C(C=C3OC)F)C(C)C)C4=CC(=CC(=C4)C(F)(F)F)C(F)(F)F
Size	10mg
Supplier Page	http://www.selleckchem.com/products/anacetrapib-mk-0859.html
Additional Information	https://file.selleck.cn/downloads/struct/Anacetrapib-chemical-structure-s2748.gif